Procaine hydrochloride oral stabilised

Drug Profile

Procaine hydrochloride oral stabilised

Alternative Names: Anticort; Procaine oral stabilsed - Samaritan Pharmaceuticals; Sp 6310; SP-01; SP-01A; SP-6310; SP001

Latest Information Update: 18 Jan 2011

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Georgetown University
  • Developer Pharmaplaz; Samaritan Pharmaceuticals
  • Class Aminobenzoic acids; Antidepressants; Antivirals; Benzoic acids; Local anaesthetics; Small molecules
  • Mechanism of Action Hormone modulators; Immunosuppressants; Monoamine oxidase inhibitors; Sodium channel antagonists; Virus replication inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported HIV infections; Major depressive disorder
  • Discontinued Alzheimer's disease

Most Recent Events

  • 24 Jun 2018 Biomarkers information updated
  • 18 Jan 2011 No development reported - Phase-II/III for HIV infections in USA (PO)
  • 18 Jan 2011 No development reported - Registered for Depression in Romania (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top